Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 701–800 of 898
Muscle Wasting in the Hospitalised COPD Patients—How Can it Be Prevented and Treated?
Cahill, T., & Ahmed, M. (2018) · Current Geriatrics Reports · doi:10.1007/s13670-018-0245-1 · Cited by 1
Habitual gait speed: a novel prognostic marker in COPD?
Kon, S. S. C. (2015) · Spiral (Imperial College London) · doi:10.25560/56925 · Cited by 1
Chronic obstructive pulmonary disease and the metabolic syndrome: The state of the problem (review)
Вютрих, К. А., Владимировна, К. Л., & Lasik, V. V. (2017) · Vestnik of Saint Petersburg University Medicine · doi:10.21638/11701/spbu11.2017.102 · Cited by 1
S, S. K. K., Maharani, B., Babu, R. V., & Prakash, M. (2019) · Southwest Journal of Pulmonary and Critical Care · doi:10.13175/swjpcc021-19 · Cited by 1
METABOLIC PHENOTYPES OF COPD: PECULIARITIES OF PATIENT MANAGEMENT
Demchuk, H., Mostovoy, Y. M., & Poberezhets, V. (2019) · Asthma and allergy · doi:10.31655/2307-3373-2019-2-39-45 · Cited by 1
Filatova, O. V., Bogdanova, T. A., & Томилова, И. Н. (2020) · Экология человека · doi:10.33396/1728-0869-2020-2-24-32 · Cited by 1
Düz, M. E., & Balcı, A. (2021) · Journal of Contemporary Medicine · doi:10.16899/jcm.829476 · Cited by 1
Truong, U. P., Pham, L.-A. T., Huynh, V.-A. N., Trần, T. V. T., & To, K. G. (2021) · Y HOC TP HO CHI MINH · doi:10.32895/ump.mpr.5.3.5 · Cited by 1
Frailty syndrome in patients with respiratory diseases
Bazdyrev, E. D., Gofman, L. S., & Барбараш, О. Л. (2022) · PULMONOLOGIYA · doi:10.18093/0869-0189-2022-32-2-244-252 · Cited by 1
Nutrición en fibrosis pulmonar idiopática: el trabajo multidisciplinario como abordaje del futuro
Barcos, V. (2022) · Respirar · doi:10.55720/respirar.14.4.7 · Cited by 1
Srigiripura, C. V., Chaya, S. K., Siddaiah, J. B., Mahesh, P. A., & Urooj, A. (2023) · The North African Journal of Food and Nutrition Research · doi:10.51745/najfnr.7.16.85-100 · Cited by 1
Brath, M. S. G., Alsted, S. D., Sahakyan, M., Mark, E. B., Frøkjær, J. B., Rasmussen, H. H., Østergaard, L. R., Christensen, R. E., & Weinreich, U. M. (2024) · Advances in respiratory medicine · doi:10.3390/arm92020015 · Cited by 1
Comorbidities in COPD patients
Djebaili, R. (2023) · Batna Journal of Medical Sciences (BJMS) · doi:10.48087/bjmsoa.2023.10116 · Cited by 1
Verhees, K. J. P. (2013) · Research Publications (Maastricht University) · doi:10.26481/dis.20130619kv · Cited by 1
Wardini, R., Rizk, A., Chan-Thim, E., Moullec, G., de Lorimier, M., & Pepin, V. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4853 · Cited by 1
Skeletal muscle dysfunction in people with COPD and recipients of lung transplants
Mathur, S. (2010) · cIRcle (University of British Columbia) · doi:10.14288/1.0077018 · Cited by 1
Guàrdia, P., & Sergi (2015) · Repositori digital de la UPF (Universitat Pompeu Fabra) · Cited by 1
Avaliação dos marcadores prognósticos de pacientes com DPOC no período de nove anos
Prudente, R. (2016) · Americanae (AECID Library) · Cited by 1
Utility of the new gold classification for COPD in alpha one antitrypsin deficiency
Pillai, A. (2017) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Marino, D. M. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
The role of quantitative CT image analysis in understanding COPD
Ostridge, K. (2017) · ePrints Soton (University of Southampton) · Cited by 1
Phénotypes et trajectoires des patients BPCO, données issues de la cohorte PALOMB
Ouaalaya, E. H. (2020) · theses.fr (ABES) · doi:10.70675/966c09b9z2182z4569zb224z7fba00949767 · Cited by 1
Passos, L. B. D. S. (2020) · doi:10.14393/ufu.te.2021.6012 · Cited by 1
Fatores associados à ocorrência de exacerbação em pacientes com DPOC
Faganello, M. M. (2007) · Americanae (AECID Library) · Cited by 1
Chronic oxidative stress and telomere shortening
Houben, J. M. J. (2011) · Research Publications (Maastricht University) · doi:10.26481/dis.20110121jh · Cited by 1
Divo, M. J., Marín‐Oto, M., Casanova, C., López, C. C., de-Torres, J. P., Marín, J. M., Hersh, C. P., Ezponda, A., Maguire, C. A., Pinto-Plata, V., et al. (2020) · doi:10.21203/rs.3.rs-16401/v1 · Cited by 1
Body composition abnormalities in chronic respiratory disease
Machado, F. V. C. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220927fm · Cited by 1
Candemir, İ. Ç., Ergün, P., & Vitacca, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-22483-6_87-1 · Cited by 1
The effect of smoking on the severity of mechanisms of acute exacerbations of COPD
Bourne, S. C. (2008) · ePrints Soton (University of Southampton) · Cited by 1
Yip, K. P. (2023) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1
Role of sphingolipids in muscle atrophy
Zufferli, A. (2011) · theses.fr (ABES) · doi:10.70675/a3dfe403za85fz4b5fz8a8dz863bbd2fee21 · Cited by 1
Franchi, M. V. (2026) · e-space (Manchester Metropolitan University) · doi:10.83056/mmu.32434869 · Cited by 1
Annegarn, J. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121107ja
Circulating microRNA in Chronic Obstructive Pulmonary Disease
Donaldson, A. V. J. (2014) · Spiral (Imperial College London) · doi:10.25560/24776
Χρόνια αποφρακτική πνευμονοπάθεια
Κουτσοκέρα, Α. (2008) · doi:10.12681/eadd/17128
A longitudinal evaluation of novel outcome measures in chronic obstructive pulmonary disease
Albarrati, A. (2014) · ORCA Online Research @Cardiff (Cardiff University)
Counteracting malnutrition in COPD patients
Antonione, R., & Biolo, G. (2007) · ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/)
Breda, A. P. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-20072011-145309
SOPORTE NUTRICIONAL EN ENFERMEDAD PULMONAR: UNA REVISIÓN SISTEMÁTICA
Vega, C., & Rodolfo, A. (2010) · Revista Investigaciones Andina · doi:10.33132/01248146.249
The nature of cachexia in patients with heart failure and stable coronary artery disease
McEntegart, M. B. (2007) · Enlighten: Theses (The University of Glasgow)
I HAVE TO QUIT! FACTORS THAT INFLUENCE QUIT ATTEMPTS IN SMOKERS WITH COPD
Lundh, L. (2015) · Figshare
Monitoring patients with COPD in primary care
van den Bemt, E. A. J. M. (2008) · Radboud Repository (Radboud University)
Acute regulation of skeletal muscle protein metabolism by nutrients, exercise and hypoxia
Etheridge, T. (2010) · University of Brighton Repository (University of Brighton)
Decision Making in Chronic Hypercapnic Respiratory Failure
Wouters, E. F. �. (2007) · CHEST Journal · doi:10.1378/chest.07-0412
Self-citationUn patient emphysémateux dénutri
Pison, C. M., Crétier, P., Frumy, F., Danton, A., Vivodtzev, I., & Borel, J. (2012) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2012.06.002
Bone imaging and strength in chronic obstructive pulmonary disease
Romme, E. A. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140220er
The extra-pulmonary effects of chronic obstructive pulmonary disease (COPD)
John, M. (2014) · Nottingham ePrints (University of Nottingham)
Lee, I. S., Kim, Y. S., Kang, Y. A., & Ahn, C. (2013) · European Respiratory Journal · doi:10.1183/13993003/erj.42.suppl_57.p3445
Hart, N. (2007) · PubMed Central
Sarcopenia en pacientes con diabetes mellitus tipo 2.
Ruiz, V., & Carlos, J. (2015) · RUIdeRA - Institutional University Repository (University of Castilla-La Mancha)
Clinical Implications of Overweight and Obesity in Chronic Obstructive Pulmonary Disease
Haagen, E., & Jonker, R. (2011)
Chapman, K. (2015) · Tuwhera (Auckland University of Technology)
Outcome Measures and Prognostic Markers for COPD
Cazzola, M., & Make, B. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-357-8_4
Thibault, R., Samaras, N., Samaras, D., Chambellan, A., & Pichard, C. (2016) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2015.12.008
Variability of lean mass depletion in chronic obstructive pulmonary disease
Burke, H., Wojtas, M. M., Wilkinson, T. M. A., & Wootton, S. A. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115001846
Horie, J., Hayashi, S., Tanaka, M., Anami, K., & Horikawa, E. (2012) · 体力科學 · doi:10.7600/jspfsm.61.125
Cardiopulmonary manifestations in chronic obstructive pulmonary disease (COPD)
Alhaddad, M. (2015) · Nottingham ePrints (University of Nottingham)
Wesseling, G., & van Schayck, O. C. P. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2006.561
Body Mass Index in COPD Mortality: Response
Budweiser, S., & Jörres, R. A. (2008) · CHEST Journal · doi:10.1378/chest.07-2509
Kadam, S. G. D. O. P. M., Gothi, D., & Joshi, J. M. (2016) · International Journal of Biomedical Research · doi:10.7439/ijbr.v7i8.3434
Rahman, H. H. (2016) · Digital Commons - University of South Florida (University of South Florida)
Горовенко, Н. Г., Stupnytska, G., & Podolskaya, S. V. (2015)
ACE-inhibition and skeletal muscle dysfunction in chronic obstructive pulmonary disease
Shrikrishnapalasuriyar, D. (2013) · Spiral (Imperial College London) · doi:10.25560/39299
Beukes, D. C. (2014) · SUNScholar (Stellenbosch University)
Uscatescu, I. (2017) · Spectrum Research Repository (Concordia University)
Computational modeling of metabolite dependencies: From metabolomics data to biochemical networks
Krumsiek, J. (2012) · mediaTUM (Technical University of Munich)
Outcomes of pulmonary rehabilitation in chronic obstructive pulmonary disease
Luk, E. K. (2017) · Minerva Access (University of Melbourne)
Palliative Care and Rehabilitation in Hospitalized Patients with Respiratory Failure
Kashkouli, P., & Hardin, K. A. (2017) · Hospital Medicine Clinics · doi:10.1016/j.ehmc.2017.05.013
Non-pharmacologic Management: LVR, Rehabilitation, and Nutrition
Lee, S. W., & Kim, E. M. (2017) · Springer eBooks · doi:10.1007/978-3-662-47178-4_17
김샛별 (2013) · YUHSpace (Yonsei University Medical Library)
Capacidad de esfuerzo, actividad física y estado nutricional en pacientes con EPOC
Espinosa, E. V. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Balañá Corberó, A., & Ana, A. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Elshabacy, F. A., El-Rahman, S. K. A., El-Maghraby, A., & Amer, E. (2015) · Egyptian Journal of Rheumatology & Clinical Immunology · doi:10.21608/ejrci.2015.9314
Martín, P., & María, E. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
The Body (Weight and Composition) of Evidence in COPD
Spelta, F. (2018) · International Journal of Pulmonary & Respiratory Sciences · doi:10.19080/ijoprs.2018.03.555622
Santos, D. M. (2017) · Institutional Repository of the Federal University of Sergipe (Universidade Federal de Sergipe)
Srdić, D. (2017) · Repository of the Medical Faculty of the University of Zagreb (University of Zagreb)
The multisystemic burden of chronic obstructive pulmonary disease: a longitudinal study
Galesanu, R. G. (2010)
Skeletal muscle mitochondrial clearance: translation to COPD
Leermakers (2019) · Research Publications (Maastricht University) · doi:10.26481/dis.20190405pl
Marino, D. M. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Raste, Y. (2016) · Spiral (Imperial College London) · doi:10.25560/55133
Nutritional phenotyping in COPD
Naghibi, M. (2017) · ePrints Soton (University of Southampton)
Catteau, M. (2019) · theses.fr (ABES) · doi:10.70675/73901f7az2fffz4a60zbe08z91a3ea189626
Regulation of skeletal muscle mitochondrial biogenesis by GSK-3β
Frank, T. W. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20200403wt
Rinaldi, S. (2020) · Scholarship@Western (Western University)
Aspectos nutricionais na doença pulmonar
Baelz, K., Goulart, C. D. L., da Silva, A. L. G., Carvalho, L. L., & Poll, F. A. (2020) · Revista Interdisciplinar de Promoção da Saúde · doi:10.17058/rips.v2i3.14073
van der Held-Horinga, G. A., Stuber, J. M., MacDonald-Ottevanger, M.-S., Kanten, A. R. V., & van Venrooij, L. M. W. (2020) · Topics in Clinical Nutrition · doi:10.1097/tin.0000000000000232
Mostarda, C. T., Barboza, C. D. A., Cutrim, A. L. C., Silva‐Filho, A. C., Dias, C. J. M., Brito-Monzani, J. D. O., & Rodrigues, B. (2021) · Clinics · doi:10.6061/clinics/2021/e1826
Recognising end of life in patients with COPD: the value of collaborative care
Dury, R. (2020) · Greenwich Academic Literature Archive (University of Greenwich)
Xiong, M., Zhao, Z., Nie, Q., Shi, Z., Wu, B., Yang, H., Fang, Y., Song, Y., He, X., Wang, M. E., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-484633/v1
Avcı, S. (2021) · Acibadem Universitesi Saglik Bilimleri Dergisi · doi:10.31067/acusaglik.850937
Kaya, F., Özgül, E., Balcı, A., Bozkurt, E., & Atay, E. (2021) · Health Sciences Quarterly · doi:10.26900/hsq.1.2.04
Xiong, M., Zhao, Z., Nie, Q., Shi, Z., Wu, B., Song, Y., He, X., Wang, M. E., & Hu, K. (2021) · Research Square · doi:10.21203/rs.3.rs-688417/v1
Severe exacerbations and acute respiratory failure in COPD
Sprooten, R. T. M. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211008rs
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.